MAP2K7 and type 2 diabetes mellitus: In the present study, we describe the antidiabetic effect of MEK inhibition with these MEK inhibitors in db/db mice, a T2D animal model, and explore the mechanism underlying the glucose lowering effect of MEK1 inhibition.